Preliminary screening of type IV secretion system in divergent geographic sources of clostridium difficile

Experimental and Therapeutic Medicine

Volumn 14, Issue 5, 2017, Pages 4405-4410

  Li, Na ^a   Jia, Hongbing ^b   Yang, Hui ^b   Ji, Bing ^a   Liu, Yongyun ^a   Peng, Xinguo ^a   Cheng, Ying ^c   Zhang, Wen ^c  

^a BINZHOU MEDICAL UNIVERSITY   (China)

^b CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Clostridium difficile; Multilocus sequence typing; Sequencing type; Type IV secretion system

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; ENTEROTOXIN; TOXIN;

ARTICLE; BACTERIAL SECRETION SYSTEM; BACTERIUM CULTURE; CLINICAL ARTICLE; CYTOTOXICITY; DNA EXTRACTION; GENE AMPLIFICATION; GENOTYPE; GEOGRAPHY; HUMAN; MICROBIAL DIVERSITY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; POLYMERASE CHAIN REACTION; SCREENING; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TYPE IV SECRETION SYSTEM;

EID: 85030214243     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2017.5065     Document Type: Article

References (20)

1. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, Monnet DL, van Dissel JT and Kuijper EJ; ECDIS Study Group: Clostridium difficile infection in Europe: A hospital-based survey. The Lancet 377: 63-73, 2011.
2. Kuijper EJ, Coignard B and Tüll P; ESCMID Study Group for Clostridium difficile; EU Member States; European Centre for Disease Prevention and Control: Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 12 (Suppl 6): S2-S18, 2006.
3. Huang H, Wu S, Wang M, Zhang Y, Fang H, Palmgren AC, Weintraub A and Nord CE: Clostridium difficile infections in a Shanghai hospital: Antimicrobial resistance, toxin profiles and ribotypes. Int J Antimicrob Agents 33: 339-342, 2009.
4. Wilkins TD and Lyerly DM: Clostridium difficile testing: After 20 years, still challenging. J Clin Microbiol 41: 531-534, 2003.
5. Zhang W, Rong C, Chen C and Gao GF: Type-IVC Secretion system: A novel subclass of type IV secretion system (T4SS) common existing in gram-positive genus Streptococcus. Plos One 7: e46390, 2012.
6. Rupnik M: How to detect Clostridium difficile variant strains in a routine laboratory. Clin Microbiol Infect 7: 417-420, 2001.
7. He M, Sebaihia M, Lawley TD, Stabler RA, Dawson LF, Martin MJ, Holt KE, Seth-Smith HM, Quail MA, Rance R, et al: Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci USA 107: 7527-7532, 2010.
8. Janvilisri T, Scaria J, Thompson AD, Nicholson A, Limbago BM, Arroyo LG, Songer JG, Gröhn YT and Chang YF: Microarray identification of Clostridium difficile core components and divergent regions associated with host origin. J Bacteriol 191: 3881-3891, 2009.
9. Yan Q, Zhang J, Chen C, Zhou H, Du P, Cui Z, Cen R, Liu L, Li W, Cao B, et al: Multilocus sequence typing (MLST) analysis of 104 Clostridium difficile strains from China. Epidemiol Infect 4: 195-199, 2013.
10. Lemme L, Halluin A, Pestel-Caron M, Lemeland JF and Pons JL: Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types. J Clin Microbiol 42: 2609-2617, 2004.
11. Kato H, Kato N, Watanabe K, Iwai N, Nakamura H, Yamamoto T, Suzuki K, Kim SM, Chong Y and Wasito EB: Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol 36: 2178-2182, 1998.
12. Griffiths D, Fawley W, Kachrimanidou M, Bowden R, Crook DW, Fung R, Golubchik T, Harding RM, Jeffery KJ, Jolley KA, et al: Multilocus sequence typing of Clostridium difficile. J ClinMicrobiol 48: 770-778, 2010.
13. Cheng Y, Du P, Chen C, Yan S, Jia H, Wang J, Yan Q, Feng H and Lu J: Toxin A-negative, toxin B-positive Clostridium difficile infection diagnosed by polymerase chain reaction. Infect Control Hosp Epidemiol 32: 520-522, 2011.
14. Govind R and Dupuy B: Secretion of Clostridium difficile toxins A and B requires the holin-like protein TcdE. PLoS Pathog 8: e1002727, 2012.
15. Olling A, Seehase S, Minton NP, Tatge H, Schröter S, Kohlscheen S, Pich A, Just I and Gerhard R: Release of TcdA and TcdB from Clostridium difficile cdi 630 is not affected by functional inactivation of the tcdE gene. Microb Pathog 52: 92-100, 2012.
16. Brouwer MS, Roberts AP, Hussain H, Williams RJ, Allan E and Mullany P: Horizontal gene transfer converts non-toxigenic Clostridium difficile strains into toxin producers. Nat Commun 4: 2061, 2013.
17. Segal G, Feldman M and Zusman T: The Icm/Dot type-IV secretion systems of Legionella pneumophila and Coxiella burnetii. FEMS Microbiol Rev 29: 65-81, 2005.
18. Ninio S and Roy CR: Effector proteins translocated by Legionella pneumophila: Strength in numbers. Trends Microbiol 15: 372-380, 2007.
19. Wang P, Xiong Y, Lan R, Ye C, Wang H, Ren J, Jing H, Wang Y, Zhou Z, Cui Z, et al: pO157_Sal, a novel conjugative plasmid detected in outbreak isolates of escherichia coli O157:H7. J Clin Microbiol 49: 1594-1597, 2011.
20. Saenz HL, Engel P, Stoeckli MC, Lanz C, Raddatz G, Vayssier-Taussat M, Birtles R, Schuster SC and Dehio C: Genomic analysis of Bartonella identifies type IV secretion systems as host adaptability factors. Nat Genet 39: 1469-1476, 2007.